Related Experiment Video
Updated: Jul 25, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Weight loss during follow-up in patients with acute heart failure: From the KCHF registry
Yuta Seko1, Takao Kato1, Takeshi Morimoto2
1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Insights
Significant weight loss after acute heart failure discharge is linked to increased mortality. Monitoring weight changes post-discharge is crucial for predicting outcomes in heart failure patients.
Area of Science:
- Cardiology
- Heart Failure Research
- Clinical Outcomes
Background:
- Prognostic implications of post-discharge weight loss in acute heart failure (AHF) are not well-defined.
- Understanding weight dynamics is key for managing AHF patients.
Purpose of the Study:
- To investigate the association between weight loss from discharge to 6-month follow-up and clinical outcomes in AHF patients.
Main Methods:
- Analysis of 686 AHF patients from the Kyoto Congestive Heart Failure registry.
- Patients categorized into weight loss (≥5% decrease) and no weight loss groups at 6 months.
- Longitudinal follow-up to assess clinical outcomes.
Main Results:
- 13.1% of patients experienced ≥5% weight loss by 6 months.
- Weight loss group showed distinct clinical characteristics including lower blood pressure and higher natriuretic peptide levels.
- The 6-month cumulative incidence of all-cause death was significantly higher in the weight loss group (14.2% vs. 4.3%).
Conclusions:
- A body weight loss of ≥5% at 6 months post-discharge is associated with increased risk of all-cause death in AHF patients.
- This finding highlights the prognostic significance of post-discharge weight changes.
Backgrounds:
The prognostic implication of weight loss after discharge from acute heart failure (AHF) remains unclear. We sought to investigate the association of weight loss between discharge and 6-month visit with subsequent clinical outcomes in patients with AHF.
Methods:
We analyzed 686 patients with AHF in the prospective longitudinal follow-up study derived from the Kyoto Congestive Heart Failure registry, and divided them into 2 groups based on the weight loss at 6-month index visit. We defined the weight loss as ≥ 5% decrease in body weight from discharge to 6-month index visit.
Results:
There were 90 patients (13.1%) with a weight loss at 6-month visit. Patients in the weight loss group compared with those in the no weight loss group had higher body weight at discharge and lower body weight at 6-mont visit. Patients in the weight loss group had a lower systolic blood pressure, higher brain-type natriuretic peptide, lower serum albumin, lower hemoglobin, higher prevalence of heart failure with reduced ejection fraction at 6-month visit, and a lower prescription rate of inhibitors of renin-angiotensin system than those in the no weight loss group. The cumulative 6-month incidence of all-cause death was significantly higher in the weight loss group than in the no weight loss group (14.2% and 4.3%, log-rank P<0.001). The excess adjusted risk of the weight loss group relative to the no weight loss group remained significant for all-cause death (HR 2.39, 95%CI 1.01-5.65, P = 0.048).
Conclusion:
Body weight loss of ≥5% at 6-month visit after discharge was associated with subsequent all-cause death in patients with AHF.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Mitral Regurgitation IV: Nursing Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy VI: Nursing Management
Heart Failure III: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management

